A Study to Assess the Availability of Oral Primaquine and Its Inert Metabolite, Carboxyprimaquine, in the Body
Conditions: Healthy; Pharmacokinetic Interventions: Drug: Regimen 1 (Oral primaquine); Drug: Regimen 2 (IV primaquine phosphate); Drug: Regimen 3 (IV carboxyprimaquine) Sponsors: University of Oxford; Mahidol Oxford Tropical Medicine Research Unit; Faculty of Tropical Medicine, Mahidol University Bangkok, Thailand Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 10, 2023 Category: Research Source Type: clinical trials